Jian Wu photo
Jian Wu
Lawyer and Regional Manager, APAC
Shanghai
43rd Floor
HKRI Centre One, HKRI Taikoo Hui
288 Shimen Yi Road
Shanghai, 200041
People's Republic of China (PRC)
+86 130 6165 0071
Shanghai
43rd Floor
HKRI Centre One, HKRI Taikoo Hui
288 Shimen Yi Road
Shanghai, 200041
People's Republic of China (PRC)
+86 130 6165 0071

Jian Wu represents clients in cross-border matters involving high-stakes commercial disputes and investigations across the Asia Pacific region (APAC) and serves as the firm’s Regional Manager of APAC. Mr. Wu has particular experience with multijurisdictional investigations and compliance reviews involving allegations of fraud, bribery, corruption and money laundering. He frequently advises state-owned enterprises, multinational corporations and financial institutions on global compliance matters in terms of anti-corruption, data privacy, export controls, as well as sanctions imposed by government authorities. He is expertized in helping Chinese companies in navigating potential enforcement actions by multilateral development banks (such as the World Bank Group, the Asian Development Bank and the African Development Bank) as a result of alleged wrongdoing.

Mr. Wu has acted in a wide range of complex China-related disputes involving governments, state-owned enterprises, multinational corporations and high-net-worth individuals (HNWIs) including litigations in Hong Kong, the United States, the United Kingdom and other offshore jurisdictions such as the British Virgin Islands and Cayman Islands, as well as arbitrations under the Hong Kong International Arbitration Center (HKIAC) and International Chamber of Commerce (ICC). He helps clients tailor, design, develop and implement global strategies across multiple jurisdictions for enforcement of high-stakes judgments and awards.  

Mr. Wu also counsels HNWIs and senior management of institutional clients facing sensitive investigations or enforcement proceedings initiated by various government authorities such as the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC).

Before joining Kobre & Kim, Mr. Wu practiced at Paul Hastings, focusing on sensitive investigations and compliance reviews. Prior to that, he practiced at Mayer Brown JSM in Beijing, China and Hong Kong, where he represented Chinese enterprises in overseas court proceedings and advised foreign enterprises in litigation, bankruptcy and investigation matters that have a connection with China.

Admissions

  • New York

Education

  • New York University School of Law, LLM
  • China University of Hong Kong, LLM
  • China University of Political Science and Law, LLB

Languages

  • Mandarin

Accolades

  • The Legal 500 Asia-Pacific, Regulatory/Compliance - China
  • The Legal 500 Asia-Pacific, Dispute Resolution: Litigation - China

Select Engagements

  • Representation of an Asia-based business executive and his affiliated entities in global legal matters arising out of allegations of fraud, bribery, and money laundering, which involve criminal investigations and civil asset forfeiture proceedings brought by the U.S. Department of Justice, as well as additional legal actions from authorities located in Switzerland, Saudi Arabia, the United Arab Emirates, Singapore and various other countries and regions, involving several billions of USD in controversy.
  • Representation of a senior officer of a Chinese company in criminal investigations brought by the U.S. authorities into alleged fraud, corruption and other risk management issues in relation to the company’s operations in the U.S.
  • Representation of U.S. subsidiaries of a Chinese company in criminal investigations brought by the U.S. Department of Justice into alleged bribery and corruption in relation to the company’s operations in Asia and Africa.
  • Representation of an international petroleum and gas company in the Delaware civil proceedings against its competitors headquartered in Spain and Argentina.
  • Representation of a multinational medical device corporation in internal investigations of its operations in China in connection with voluntary disclosure to the U.S. Department of Justice relating to potential FCPA violations.
  • Representation of a European multinational business software corporation in internal investigations of its operations in Greater China in connection with whistleblower allegations, revenue recognition and suspected fraudulent practices.
  • Representation of a major Chinese state-owned corporation as independent investigator in the context of the corporation’s debarment by a multilateral development bank following allegations that the corporation misrepresented its past experiences in bidding tenders.
  • Representation of an Asia-based company as independent investigator on sanctions for integrity violations imposed by Asian Development Bank.
  • Representation of a Chinese internet software corporation on sanction compliance issues relating to U.S. economic sanctions, trade controls, data privacy, and cross-border regulatory issues leading to potential enforcement risks.
  • Representation of a U.S. multinational technology corporation on sanction compliance issues in connection with companies on the Entity List imposed by U.S. Department of Commerce’s Bureau of Industry and Security.
  • Representation of a Chinese integrated technology manufacturing corporation for compliance relating to U.S. economic sanctions and trade controls, and potential litigation arising out of technology transfer and related issues.
  • Representation of a British multinational pharmaceutical company in internal compliance reviews of its operations in China in connection with its global acquisition with another leading pharmaceutical company.
  • Representation of a Canadian telecommunication corporation on winding up of its businesses and operations in the Asia Pacific region.
 

Professional & Community Involvement

  • American Bar Association, China Committee, Vice Chair
  • Asian American Bar Association of New York, Asia Practice Committee, Co-Chair

Publications & Presentations

  • Co-author, "'Belt and Road Initiative' Chinese Companies Should Pay Attention to MDB Compliance (中国企业“一带一路”走出去需重视多边开发银行合规)" (Guancha News, August 2021)
  • Speaker, “Potential Impact of Recent Executive Orders on Chinese Investments and Business in the United States” (New York City Bar Association, Webinar, September 2020)
  • Co-author, “Why Anti-Bribery Enforcement Scrutiny in China is Here to Stay” (Global Investigations Review, May 2020)
  • Speaker, “Dealing with Chinese Parties: Litigation, White Collar Crimes, and Transactional Opportunities In The Era of the Trade War” (New York City Bar Association, New York, October 2019)
  • Speaker, “The Long Arm of the Law: What the Extra-Territorial Tools of the Department of Justice Mean for Asian Companies and Individuals” (New York City Bar Association, New York, September 2019)
  • Speaker, “China’s Belt and Road Initiative: How to Navigate New Business Opportunities” (New York City Bar Association, New York, June 2019)
  • Speaker, “Risks and Strategies for Foreign Companies Involved in U.S. Litigation” (Asian American Bar Association of New York, New York, March 2018)

Credentials

Admissions

  • New York

Education

  • New York University School of Law, LLM
  • China University of Hong Kong, LLM
  • China University of Political Science and Law, LLB

Languages

  • English
  • Mandarin

Accolades

  • The Legal 500 Asia-Pacific, Regulatory/Compliance - China
  • The Legal 500 Asia-Pacific, Dispute Resolution: Litigation - China

Engagements

  • Representation of an Asia-based business executive and his affiliated entities in global legal matters arising out of allegations of fraud, bribery, and money laundering, which involve criminal investigations and civil asset forfeiture proceedings brought by the U.S. Department of Justice, as well as additional legal actions from authorities located in Switzerland, Saudi Arabia, the United Arab Emirates, Singapore and various other countries and regions, involving several billions of USD in controversy.
  • Representation of a senior officer of a Chinese company in criminal investigations brought by the U.S. authorities into alleged fraud, corruption and other risk management issues in relation to the company’s operations in the U.S.
  • Representation of U.S. subsidiaries of a Chinese company in criminal investigations brought by the U.S. Department of Justice into alleged bribery and corruption in relation to the company’s operations in Asia and Africa.
  • Representation of an international petroleum and gas company in the Delaware civil proceedings against its competitors headquartered in Spain and Argentina.
  • Representation of a multinational medical device corporation in internal investigations of its operations in China in connection with voluntary disclosure to the U.S. Department of Justice relating to potential FCPA violations.
  • Representation of a European multinational business software corporation in internal investigations of its operations in Greater China in connection with whistleblower allegations, revenue recognition and suspected fraudulent practices.
  • Representation of a major Chinese state-owned corporation as independent investigator in the context of the corporation’s debarment by a multilateral development bank following allegations that the corporation misrepresented its past experiences in bidding tenders.
  • Representation of an Asia-based company as independent investigator on sanctions for integrity violations imposed by Asian Development Bank.
  • Representation of a Chinese internet software corporation on sanction compliance issues relating to U.S. economic sanctions, trade controls, data privacy, and cross-border regulatory issues leading to potential enforcement risks.
  • Representation of a U.S. multinational technology corporation on sanction compliance issues in connection with companies on the Entity List imposed by U.S. Department of Commerce’s Bureau of Industry and Security.
  • Representation of a Chinese integrated technology manufacturing corporation for compliance relating to U.S. economic sanctions and trade controls, and potential litigation arising out of technology transfer and related issues.
  • Representation of a British multinational pharmaceutical company in internal compliance reviews of its operations in China in connection with its global acquisition with another leading pharmaceutical company.
  • Representation of a Canadian telecommunication corporation on winding up of its businesses and operations in the Asia Pacific region.

Professional & Community Involvement

  • American Bar Association, China Committee, Vice Chair
  • Asian American Bar Association of New York, Asia Practice Committee, Co-Chair

Publications & Presentations

  • Co-author, "'Belt and Road Initiative' Chinese Companies Should Pay Attention to MDB Compliance (中国企业“一带一路”走出去需重视多边开发银行合规)" (Guancha News, August 2021)
  • Speaker, “Potential Impact of Recent Executive Orders on Chinese Investments and Business in the United States” (New York City Bar Association, Webinar, September 2020)
  • Co-author, “Why Anti-Bribery Enforcement Scrutiny in China is Here to Stay” (Global Investigations Review, May 2020)
  • Speaker, “Dealing with Chinese Parties: Litigation, White Collar Crimes, and Transactional Opportunities In The Era of the Trade War” (New York City Bar Association, New York, October 2019)
  • Speaker, “The Long Arm of the Law: What the Extra-Territorial Tools of the Department of Justice Mean for Asian Companies and Individuals” (New York City Bar Association, New York, September 2019)
  • Speaker, “China’s Belt and Road Initiative: How to Navigate New Business Opportunities” (New York City Bar Association, New York, June 2019)
  • Speaker, “Risks and Strategies for Foreign Companies Involved in U.S. Litigation” (Asian American Bar Association of New York, New York, March 2018)